Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > I don't understand why...
View:
Post by gojotv! on Mar 15, 2023 2:11pm

I don't understand why...

...the company won't inform shareholders about the BTD (and possible AA) application with the FDA. IR refuses to say if it's even been filed.
They claim it's not "material", but as far as I can see, the share price right now entirely hinges on this news... Are shareholders not entitled to know if stated timelines are being respected? Or if there's a hold up - why?
I just don't like when companies give their shareholders the radio silence. It's never good.
Crossing my fingers I'm wrong... 
GLTA real investors!
Comment by Longholder99 on Mar 15, 2023 2:36pm
If they applied it isn't meaningful frankly as until it's approved the company is no further ahead.  If they announced said application the market would likely respond as it has. Based on ability to generate revenue which will not change until the game changing cancer treatment we have all invested in can be sold to consumers.  Like any other business. 
Comment by plantrader on Mar 15, 2023 2:53pm
You and me both. IMO typically in the world of microcaps silence is not a good thing. It often means the company prefers to conceal missteps and/or delays. I'm not saying that's the case with Theralase, but the company knows full-well that they are way behind schedule for lots of obvious reasons so a little bit of extra/pointed communication would be nice. We're stuck waiting either ...more  
Comment by Eoganacht on Mar 15, 2023 3:06pm
We've had "radio silence" numerous time over the years with Theralase. Occasionally there's bad news, but 9 times out of 10 it's all good. Big picture? Theralase has got this.
Comment by ScienceFirst on Mar 15, 2023 4:35pm
Still some insecures, as always? TLT did what it had to do; reach that 25 patients milestone.  Present to ASCO-GU, and already registered for AUA and published its plan on Jan. 3rd to show what's coming up, mentioned they are engaging into jv discussions with big pharmas in 2023/2024 and still, it's not enough for some!!! TLT management has more incentives than any of us to make it ...more  
Comment by 99942Apophis on Mar 15, 2023 3:07pm
Applying for BTD isn't material gojotv however whats worrisome is because of the run on banks some shareholders are selling which could be the wrong move. Since we are in a prime time slot for news those shareholders that sold playing safe might be the worst decision. Should BTD come through in our current time slot the market will put the share value out 6 to 12 months which will not only ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250